GLP-1 medications have changed the landscape of medical weight loss in a significant way. If you have been paying attention to the conversation around weight management in recent years, you have probably heard the names semaglutide and tirzepatide,  often under brand names like Ozempic, Wegovy, and Mounjaro.

But knowing the names is different from knowing how these medications work, how they differ, and which one might be the right fit for you. That is what this article is designed to help with.

If you are considering GLP-1 medication for weight loss in the O’Fallon or St. Louis area, here is what you need to know before your first appointment.

What Are GLP-1 Medications

GLP-1 stands for glucagon-like peptide-1. It is a hormone that the body naturally produces in the gut after eating. It plays a role in several important processes:

• Telling the pancreas to release insulin in response to food
• Slowing gastric emptying (how quickly food moves from the stomach to the small intestine)
• Signaling the brain that you are full
• Reducing appetite and food cravings

GLP-1 receptor agonists are medications that mimic this hormone, amplifying its effects in a controlled and sustained way. The result is reduced hunger, slower digestion, and — in clinical studies — meaningful weight loss for many patients.

These medications are not stimulants. They are not appetite suppressants in the traditional sense. They work by influencing the body’s own hormonal signaling system.

Semaglutide: What It Is and How It Works

Semaglutide is a GLP-1 receptor agonist that has been available for several years, first as a diabetes medication (Ozempic) and later as a higher-dose weight loss formulation (Wegovy). It is administered as a once-weekly injection.

Clinical trials have shown that semaglutide can produce significant weight loss when combined with lifestyle changes. In the STEP trials, participants lost an average of around 15 percent of their body weight over 68 weeks. Results vary by individual, and weight loss tends to be gradual and progressive over time.

Semaglutide works by activating GLP-1 receptors throughout the body. The primary mechanism is appetite reduction and slowing of gastric emptying, which helps patients feel satisfied with smaller amounts of food and reduces the urge to snack or overeat.

Common side effects include nausea, particularly early in treatment as the dose is increased. Most patients find that side effects diminish as the body adjusts. Other potential side effects include constipation, fatigue, and in some cases, vomiting.

Tirzepatide: What Makes It Different

Tirzepatide is a newer medication that takes a different approach. While semaglutide targets only GLP-1 receptors, tirzepatide is a dual agonist — it activates both GLP-1 receptors and GIP receptors (glucose-dependent insulinotropic polypeptide).

GIP is another gut hormone involved in insulin regulation and fat metabolism. By targeting both pathways simultaneously, tirzepatide appears to produce stronger effects on appetite suppression and metabolic function than GLP-1 alone.

In the SURMOUNT clinical trials, tirzepatide produced average weight loss of up to 20 to 22 percent of body weight at the highest dose — which is notable when compared to outcomes seen with semaglutide. Again, individual results vary significantly, and these figures represent averages from controlled trial settings.

Tirzepatide is administered as a once-weekly injection, similar to semaglutide. Side effects are similar as well — primarily nausea, diarrhea, and gastrointestinal discomfort, particularly during the dose escalation phase.

Semaglutide vs. Tirzepatide: A Side-by-Side Comparison

Mechanism

• Semaglutide: GLP-1 receptor agonist
• Tirzepatide: Dual GLP-1 and GIP receptor agonist

Typical Weight Loss (clinical trials)

• Semaglutide: Average approximately 15 percent of body weight
• Tirzepatide: Average up to 20 to 22 percent of body weight at highest dose

Dosing

• Both are once-weekly injections
• Both are started at a low dose and increased gradually over several months

Side Effects

• Both share similar profiles: nausea, constipation, potential GI discomfort
• Individual tolerance varies considerably

Availability

• Both are available through Wright Choice Weight Loss in O’Fallon and St. Louis
• Availability of specific formulations may vary; your provider can advise on current options

Which One Is Right for You?

This is the question most patients arrive with, and the honest answer is: it depends. There is no universal right answer, and choosing between semaglutide and tirzepatide is not a decision to make based on what worked for someone else or what you read online.

Factors that matter include:

• Your overall health history and any existing conditions, particularly type 2 diabetes or metabolic issues
• Your weight loss goals and the amount of weight you are hoping to lose
• Your history with other weight loss approaches and how your body has responded
• Your tolerance for potential side effects
• Cost and insurance considerations, which vary significantly between the two medications
• Availability of specific formulations through your provider

The purpose of a medical weight loss consultation is to work through exactly these considerations with someone who can look at your full picture and make a thoughtful recommendation.

What Medical Weight Loss at Wright Choice Looks Like

Wright Choice Weight Loss is a medically supervised weight loss program in O’Fallon, Missouri, led by Dr. Thomas Wright. The program is designed for patients who want to lose weight with clinical support, not a one-size-fits-all approach.

When you come in for a consultation, you will have a thorough conversation about your health history, your goals, and your previous experiences with weight management. Dr. Wright will help you understand which medication might be the best fit and what a realistic treatment timeline looks like.

Patients are monitored throughout the program. Dosing is adjusted based on how you are responding. Side effects are taken seriously and managed proactively. The goal is not just weight loss — it is weight loss that is sustainable and supported.

A Note on Safety and Medical Supervision

GLP-1 medications are prescription medications. They are not appropriate for everyone, and they are not meant to be managed without medical oversight. There are contraindications to be aware of — including a personal or family history of certain thyroid conditions — and dosing requires careful titration.

Programs that offer these medications without proper evaluation and follow-up are not providing the standard of care these medications require. At Wright Choice Weight Loss, every patient receives individualized attention, monitoring, and access to Dr. Wright and his team throughout treatment.

Ready to Find Out If GLP-1 Medication Is Right for You

If you are in the O’Fallon or St. Louis area and want to explore semaglutide or tirzepatide as part of a medically supervised weight loss plan, the next step is a consultation.

You will leave with clear answers, a better understanding of your options, and a realistic picture of what these medications can offer you personally.

Contact Wright Choice Weight Loss to schedule your consultation today.